Your browser doesn't support javascript.
loading
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard, James F; Bresch, Saskia; Genge, Angela; Hewamadduma, Channa; Hinton, John; Hussain, Yessar; Juntas-Morales, Raul; Kaminski, Henry J; Maniaol, Angelina; Mantegazza, Renato; Masuda, Masayuki; Sivakumar, Kumaraswamy; Smilowski, Marek; Utsugisawa, Kimiaki; Vu, Tuan; Weiss, Michael D; Zajda, Malgorzata; Boroojerdi, Babak; Brock, Melissa; de la Borderie, Guillemette; Duda, Petra W; Lowcock, Romana; Vanderkelen, Mark; Leite, M Isabel.
Afiliação
  • Howard JF; Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: howardj@neurology.unc.edu.
  • Bresch S; Service de Neurologie, Hospital Pasteur, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Genge A; Clinical Research Unit, The Montreal Neurological Institute, Montreal, QC, Canada.
  • Hewamadduma C; Department of Neuroscience, Sheffield Institute for Translational Neurosciences (SITRAN), University of Sheffield and Sheffield Teaching Hospitals Foundation NHS Trust, Sheffield, UK.
  • Hinton J; Diagnostic and Medical Clinic, Mobile, AL, USA.
  • Hussain Y; Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
  • Juntas-Morales R; Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, Barcelona, Spain.
  • Kaminski HJ; Department of Neurology & Rehabilitation Medicine, George Washington University, Washington, DC, USA.
  • Maniaol A; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Mantegazza R; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy.
  • Masuda M; Department of Neurology, Tokyo Medical University, Tokyo, Japan.
  • Sivakumar K; Neuromuscular Clinic and Research Center, Phoenix, AZ, USA.
  • Smilowski M; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland.
  • Utsugisawa K; Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
  • Vu T; Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Weiss MD; Department of Neurology, University of Washington Medical Center, Seattle, WA, USA.
  • Zajda M; Medical University of Warsaw, Warsaw, Poland.
  • Boroojerdi B; UCB Pharma, Monheim, Germany.
  • Brock M; UCB Pharma, Raleigh, NC, USA.
  • de la Borderie G; UCB Pharma, Brussels, Belgium.
  • Duda PW; UCB Pharma, Cambridge, MA, USA.
  • Lowcock R; UCB Pharma, Slough, UK.
  • Vanderkelen M; UCB Pharma, Braine-l'Alleud, Belgium.
  • Leite MI; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Lancet Neurol ; 22(5): 395-406, 2023 05.
Article em En | MEDLINE | ID: mdl-37059508
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Miastenia Gravis Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Miastenia Gravis Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article